Total Dance Australia Blog


Would you like to become a Total Dance Australia guest contributor? Do you have stories, handy hints & tips or an inspirational message you would love to share?
Submit your ideas to info@total-dance-aus.com along with your relevant details and background and we'll be in touch Xx
Inspiring & Engaging the Dancers of Australia
How to Take Your Performance From Studio To Stage
Author: Teagan Lowe Date Posted: 13 September 2021
Comment (3)
...
Read MoreQ & A with Katherine Wiles of Opera Australia’s full time chorus
Author: Teagan Lowe Date Posted: 16 April 2021
...
Read MoreWork smart, not hard - how to work as an intelligent dancer
Author: Teagan Lowe Date Posted: 4 March 2021
Comment (2)
Work smart, not hard - how...
Read MoreTeagan Lowe - Blog Writer
Author: Teagan Lowe Date Posted: 25 February 2021
Comment (3)
Who is Teagan Lowe?...
Read MoreDancer Health & Wellness
Providing our readers with the skills and knowledge to support ...
Read MoreDancing Smarter Online
Author: Leah Van Lambaart Date Posted: 22 April 2020
Dancing Smarter Onlin...
Read MoreReflecting on 2019 and reset for a bigger and better 2020
Author: Leah Van Lambaart Date Posted: 13 December 2019
Another year ...
Read MoreHow Eating A Rainbow Can Improve Your Performances
Author: Leah Van Lambaart Date Posted: 25 October 2019
How Eating A Rainbow Can I...
Read MoreFuelling Your Energy
Author: Leah Van Lambaart Date Posted: 26 July 2019
Fuelling Your Energy...
Read MoreComments (1)
medication for the treatment of serious gram-posit
10 April 2022oritavancin, sold under the brand name orbactiv, is a novel semisynthetic glycopeptide antibiotic medication for the treatment of serious gram-positive bacterial infections. its chemical structure as a lipoglycopeptide is similar to vancomycin. the u.s. food and drug administration (fda) and the european medicines agency (ema) have approved oritavancin for treatment of acute bacterial skin and skin structure infections. in vitro activity oritavancin shares certain properties with other members of the glycopeptide class of antibiotics, which includes vancomycin, the current standard of care for serious gram-positive infections in the united states and europe. it possesses potent and rapid bactericidal activity in vitro against a broad spectrum of both resistant and susceptible gram-positive bacteria, including staphylococcus aureus, mrsa, enterococci, and streptococci. oritavancin was more active than either metronidazole or vancomycin against strains of clostridium difficile tested. oritavancin has potential use as a therapy for exposure to bacillus anthracis, the gram-positive bacterium that causes anthrax, having demonstrated efficacy in a mouse model both before and after exposure to the bacterium. mechanism the 4'-chlorobiphenylmethyl group disrupts the cell membrane of gram-positive bacteria. it also acts by inhibition of transglycosylation and inhibition of transpeptidation.